New Drug Approved for Traveler's Diarrhea
By Kathleen Doheny
Nov. 20, 2018 -- The FDA has approved a new prescription drug for traveler's diarrhea, which affects millions of people a year, cutting short vacations and other trips.
Rifamycin (Aemcolo) is expected to be on the market by mid-February, says Tom Joyce, president and CEO of Aries Pharmaceuticals, the U.S. firm licensed to distribute it here.
The antibacterial drug, taken orally, is approved for the treatment of adults with traveler's diarrhea caused by strains of Escherichia coli (E. coli) that do not involve fever or blood in the stool.
https://www.webmd.com/digestive-disorders/news/20181120/new-drug-approved-for-travelers-diarrhea
